Navigation Links
Human Genome Sciences Announces Process Development and Manufacturing Alliance With Hospira
Date:9/4/2008

d diseases. The Company's primary focus is rapid progress toward the commercialization of its two key lead drugs, Albuferon(R) (albinterferon alfa-2b) for hepatitis C and LymphoStat-B(R) (belimumab) for lupus. Phase 3 clinical trials of both drugs are ongoing.

ABthrax(TM) (raxibacumab) is in late-stage development for the treatment of inhalation anthrax, and the Company is on track to begin the delivery in fall 2008 of 20,000 doses of ABthrax to the Strategic National Stockpile under a contract entered into with the U.S. Government in June 2006. HGS also has three drugs in clinical development for the treatment of cancer, including two TRAIL receptor antibodies and a small-molecule antagonist of IAP (inhibitor of apoptosis) proteins. In addition, HGS has substantial financial rights to certain products in the GSK clinical development pipeline.

For more information about HGS, please visit the Company's web site at http://www.hgsi.com. Health professionals and patients interested in clinical trials of HGS products may inquire via e-mail to clinical_trials@hgsi.com or by calling HGS at (301) 610-5790, extension 3550.

HGS, Human Genome Sciences, ABthrax, Albuferon and LymphoStat-B are trademarks of Human Genome Sciences, Inc.

Safe Harbor Statement

This announcement contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. The forward-looking statements are based on Human Genome Sciences' current intent, belief and expectations. These statements are not guarantees of future performance and are subject to certain risks and uncertainties that are difficult to predict. Actual results may differ materially from these forward-looking statements because of the Company's unproven business model, its dependence on new technologies,
'/>"/>

SOURCE Human Genome Sciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at Thomas Weisel Conference
2. Ikaria(R) Strengthens Commercial Operations and Human Resources Leadership
3. UC Riverside researcher develops novel method to grow human embryonic stem cells
4. ArunA Biomedical Announces Exclusive Worldwide Technology Licensing Agreement to Commercialize Human Embryonic Stem Cell Derived Mesenchymal Cells
5. DSM Biologics and MorphoSys AG to Manufacture Fully Human Antibody
6. Thousands Rally in Mexico City and Call for Human Rights Protections in Global AIDS Response
7. Human Genome Sciences Announces Second Quarter 2008 Financial Results and Key Developments
8. Human Genome Sciences Appoints David P. Southwell to its Board of Directors
9. Human Genome Sciences to Sponsor Conference Call to Discuss Second Quarter 2008 Financial Results
10. New map IDs the core of the human brain
11. BioTime, Inc. and Embryome Sciences, Inc. Sign Agreement With International Stem Cell Corporation to Provide Unique Human Stem Cell Lines for Research Use

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)... LOS ANGELES, Nov. 30 /PRNewswire-Asia-FirstCall/ ...in Board: CYXN; ,China Yongxin,Pharmaceuticals, or...or and,retailer of pharmaceuticals in Northeastern...on for distribution of medicines on the Essential ...tly formalized the nation,s Essential Drug,List wh...
(Date:11/30/2009)...ewswire-FirstCall/ -- Cell Therapeutics, Inc. (CTI...new class of platinum-based anti-tumor compounds, ...i-tumor potency and activity compared to currently... ability to overcome cisplatin-resistance in cance...er titled "Novel Bis-platinum Complexes Endowed wi...
(Date:11/30/2009)... AMSTERDAM, November 30 ...ific, medical and technical products and services,...comprehensive biomedical,database which holds over...ctive, peer reviewed journals. , Embase h...w biomedical,and pharmaceutical insights. Now, new...
(Date:11/27/2009)...ewswire-FirstCall/ -- Stallergenes has been,grante...dults and children,through a Mutual Recognition Pr...R) has been marketed, was the reference Member sta...tria, Belgium, Bulgaria, Cyprus, the,Czech Republi...and, Italy,Latvia, Lithuania, Luxembourg, Malta, ...
Breaking Biology Technology:China Yongxin Pharmaceuticals Inc. to Distribute Medicines on the Essential Drug List 2China Yongxin Pharmaceuticals Inc. to Distribute Medicines on the Essential Drug List 3New Class of Platinum-Based Anti-Tumor Drugs, Bisplatinates, Demonstrates Potent Anti-Tumor Activity and Ability to Overcome Resistance to Currently Available Platinum-Based Agents 2New Class of Platinum-Based Anti-Tumor Drugs, Bisplatinates, Demonstrates Potent Anti-Tumor Activity and Ability to Overcome Resistance to Currently Available Platinum-Based Agents 3Elsevier is Re-Launching "Embase" to be a Powerful Resource Providing Deep Insights and Answers to Biomedical Researchers 2Elsevier is Re-Launching "Embase" to be a Powerful Resource Providing Deep Insights and Answers to Biomedical Researchers 3STALLERGENES is Granted a Marketing Authorization for Oralair(R) in Europe 2STALLERGENES is Granted a Marketing Authorization for Oralair(R) in Europe 3
... - Nerites Corp ., a Madison biotechnology compa...a recent round of funding, bringing the total rais... is moving toward human clinical trials to verify ...tissues together in aqueous environments, includin...atings that block bacterial adhesion to the device...
.... - Sir Ken Robinson has many stories to tell,...oint about creativity than the story of a little g...n, a senior advisor to the J. Paul Getty Trust i...pert in creativity and innovation, told the story ...Biotechnology and Medical Device Association Conf...
...ave a luncheon speech to the Chicago Bar Associati...l Revenue Generators for the 21 st Century." At ...l idea but did not put that much faith in it. My a...cused on gasoline, cigarettes, and liquor were max...reative to seek out revenue streams that could pay...
Other Biology Technology:Sir Ken Robinson: Companies, kids "get" innovation, but K-12 doesn't nurture it 2Sir Ken Robinson: Companies, kids "get" innovation, but K-12 doesn't nurture it 3Creativity, innovation extend to municipalities 2Creativity, innovation extend to municipalities 3Creativity, innovation extend to municipalities 4
(Date:11/30/2009)...dorless radioactive gas that is produced by the ra...uranium decay and is found in trace amounts natura... well as building materials, plants, animals, and ...sed as the amount of radiation that would be emitt...ir; thus the units are picocuries per liter (pCi/L...
(Date:11/26/2009)...6, 2009) Whitehead researchers have developed a n...int specific genes and proteins used by pathogens,...t human cell cultures genes are present in two cop...e mother. Gene inactivation by mutation is therefo...d, the second copy usually remains active and take...
(Date:11/25/2009)...have easy lives. In addition to mammalian immune s...emies called bacteriophages, viruses that kill hal..., bacteria and another class of microorganisms cal...nts such as deep-sea volcanic vents) manage just f...in defense system that helps protect them from man...
Breaking Biology News(10 mins):Health Physics Society recommends considering action for indoor radon below current guidelines 2Knockouts in human cells point to pathogenic targets 2Researchers discover biological basis of 'bacterial immune system' 2Researchers discover biological basis of 'bacterial immune system' 3FindFloridaLawyer com Announces the Grand Opening of Its Online Attorney Search and Legal Resource Site 57360 1FindFloridaLawyer com Announces the Grand Opening of Its Online Attorney Search and Legal Resource Site 57360 2Touro Appoints Alan Kadish M D Senior Provost and Chief Operating Officer 57356 1Touro Appoints Alan Kadish M D Senior Provost and Chief Operating Officer 57356 2Touro Appoints Alan Kadish M D Senior Provost and Chief Operating Officer 57356 3Touro Appoints Alan Kadish M D Senior Provost and Chief Operating Officer 57356 4Consumer Reports Health News 57352 1Consumer Reports Health News 57352 2Consumer Reports Health News 57352 3Consumer Reports Health News 57352 4Consumer Reports Health News 57352 5Consumer Reports Health News 57352 6
... mothers especially pregnant mothers are among t... of exercise for these women and their developing ...o not exercise. A survey examining daily activitie... larger study looking at the effect of maternal ex...among other things, that exercising during pregnan...
... benefits for adults, teens, and youngsters. It is...e during fetal growth during gestation. Now that s..., maternal exercise poses no significant risk to a.../fetus/exercise/health connection. , One importa...Maternal Exercise on Fetal Breathing Movements, it...
... / b3c newswire / - Addressing significa...man diagnostics market, InVitria has announced the...t albumin products. InVitria’s Recombinant A...perform better in diagnostics applications than bo...uman serum albumin (pHSA).  , , The advan...
Other Biology News:Differences among exercisers and nonexercisers during pregnancy 2Differences among exercisers and nonexercisers during pregnancy 3Effects of maternal exercise on fetal breathing movements 2InVitria Announces Launch of Recombinant Albumin for Diagnostics 2
...riseolusthat inhibits protein synthesis. Acts by i...te ribosomes. Reported to induce apoptosis in a va...lls, Jurkat cells, ventricular myocytes, and colon...nals and immediate early gene induction. Selective...
VersArray Hybridization Chamber from Bio-Rad
...ration system using the asymmetric flow Field Flow...rates easily with Wyatts multi-angle light scatter... well as the Optilab DSP. The combined system prov... the particles/molecules separated by the AFFF uni...
Mouse Anti-Fatty Acid Binding Protein (FABP) Antibody, TRITC (Rhodamine) Conjugated from HyTest Ltd.
Biology Products: